Tuesday, 17 November 2026 SEC EDGAR filings, as they land
ALFA USA News Straight from the SEC filing
SEC Filings

Atrium Therapeutics, Inc. — Latest News

Every SEC filing by Atrium Therapeutics, Inc. that we have reported, newest first. Each story links the original filing.

NASDAQ: RNA · Biotechnology · 2 stories

Share price
$8.27
Market cap
$141M
Revenue (annual)
$19M

Reference market data from a third-party provider, as of the most recent story (2 Nov 2026). Not a valuation or a recommendation.

Atrium Therapeutics, Inc. share price · last month
Line chart of Atrium Therapeutics, Inc.'s share price over the last month, from $7.61 on 19 Oct → $6.43 on 16 Nov.

Down 15.5% over the last month ($7.61 on 19 Oct → $6.43 on 16 Nov). Daily closing prices. Source: Yahoo Finance.

Show the prices
19 Oct$7.61
20 Oct$7.98
21 Oct$8.00
22 Oct$8.16
23 Oct$8.20
26 Oct$8.05
27 Oct$8.32
28 Oct$8.40
29 Oct$8.26
30 Oct$8.27
2 Nov$8.55
3 Nov$8.72
4 Nov$8.68
5 Nov$8.32
6 Nov$8.34
9 Nov$8.38
10 Nov$8.23
11 Nov$7.96
12 Nov$7.50
13 Nov$7.51
16 Nov$6.43
Other 1Capital Raise 1

Track Atrium Therapeutics, Inc. live

Get the next Atrium Therapeutics, Inc. SEC filing seconds after it lands.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.